Axon (AXON) COO & CFO awarded 30,560 shares in Form 4 filing

Axon Enterprise, Inc. reported an equity award event for its COO & CFO, Brittany Bagley.

Rhea-AI Filing Summary

Axon Enterprise, Inc. reported an equity award event for its COO & CFO, Brittany Bagley. On 11/13/2025, she acquired 30,560 shares of Axon common stock at a price of $0, reflecting the certification of performance conditions for the third tranche of performance-based restricted stock units (XSUs) granted on December 22, 2023 under the Axon Enterprise, Inc. 2024 eXponential Stock Plan. These XSUs relate to a tranche whose performance goals were certified as achieved by the Compensation Committee on that date. After this transaction, she beneficially owns 121,652 shares of common stock directly. The tranche is scheduled to vest on June 1, 2026, subject to continued employment, and the shares delivered will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent XSU tranche, excluding shares used to cover taxes.

Insider Trade Summary

Grant/Award: 30,560 shares

Grant/Award 1 txn

Insider Bagley Brittany

Role COO & CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,560	$0.00	$0.00

Holdings After Transaction: Common Stock — 121,652 shares (Direct)

Footnotes (1)

1. F1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the third tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on November 13, 2025 as having been met. The Tranche will vest on June 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

FAQ

What equity transaction did AXON COO & CFO Brittany Bagley report on this Form 4?

Brittany Bagley reported the acquisition of 30,560 shares of Axon common stock on 11/13/2025 at a price of $0, tied to performance-based restricted stock units (XSUs).

What is the source of the 30,560 Axon (AXON) shares reported in this Form 4?

The 30,560 shares come from the third tranche of performance-based restricted stock units granted on December 22, 2023 under the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which performance conditions were certified as met on November 13, 2025.

When will the reported XSU tranche for AXON shares vest and under what condition?

The reported tranche will vest on June 1, 2026, and this vesting is subject to Brittany Bagley’s continued employment through that date.

Is there a holding period for the Axon (AXON) shares delivered from this XSU tranche?

Yes. After vesting, the shares deliverable for the tranche are subject to a minimum holding period until the earlier of December 31, 2030 or the date a subsequent XSU tranche vests, excluding shares withheld or sold to cover taxes.

How many Axon (AXON) shares does Brittany Bagley beneficially own after this Form 4 transaction?

Following the reported transaction, Brittany Bagley beneficially owns 121,652 shares of Axon common stock directly.

What is Brittany Bagley’s role and relationship to Axon Enterprise, Inc. (AXON)?

Brittany Bagley is reported as an officer of Axon Enterprise, Inc., serving as COO & CFO, and is a reporting person for this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 05:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bagley Brittany

(Last) (First) (Middle)

17800 N 85TH ST

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO & CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A(1)		30,560	A	$0	121,652	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the third tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on November 13, 2025 as having been met. The Tranche will vest on June 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Remarks:

	/s/ Brittany Bagley by Isaiah Fields, Attorney-in-Fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.